Manufacturing OSD Forms: Key Trends Shaping the Industry

Published on: 
, ,
Pharmaceutical Technology, Pharmaceutical Technology, Trends in Manufacturing, May 2022, Volume 2022 eBook, Issue 2
Pages: 4–9

The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments.

Alternative dosage forms are helping the pharmaceutical industry tackle some of the biggest challenges associated with efficacy and patient adherence. For example, oral films that help administer treatments to pediatric and geriatric patients, and wearable injectors that enable the self-administering of high-volume treatments. Amid these innovations, it’s easy to overlook the humble tablets and capsules that have been used for generations and continue to be the most popular course of treatment around the world. The global capsule market is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2021 to 2030 (1). This amounts to approximately 700 billion units every year around the world, according to ACG data (2).

But capsules are more than the familiar favorite. Recent developments are taking oral solid dosage (OSD) solutions to new heights. Now more than ever, innovation is fueled by the need to differentiate and to deliver sustainable, advanced products in the crowded pharmaceutical market. Pharmaceutical manufacturers must also navigate evolving delivery formats, the economy of scale, complex regulatory landscapes, increasingly stressed supply chains, and digitalization, all while maintaining the highest quality standards. Therefore, it’s crucial to take steps to meet these growing challenges using the latest advanced manufacturing technologies.

Read this article in Pharmaceutical Technology's Trends in Manufacturing eBook.



1. ResearchAndMarkets, Empty Capsules Market by Product, Raw Material, Therapeutic Application and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030 (December 2021).

2. WHO, “1 in 10 Medical Products in Developing Countries is Substandard or Falsified,” (November 2017).

About the authors

Laxman Shetty is the vice president, operations; Jnanadeva Bhat is the vice president, formulation R&D (pharma and nutra); and Anita Solanki is the lead for whitepapers and publications, formulation R&D (pharma and nutra), all for ACG.

Article details

Pharmaceutical Technology
eBook: Trends in Manufacturing
May 2022
Pages: 4–9


When referring to this article, please cite it as L. Shetty, J. Bhat, and A. Solanki, "Manufacturing OSD Forms: Key Trends Shaping the Industry," Pharmaceutical Technology's Trends in Manufacturing eBook (May 2022).